To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCAPI1390 | Atovaquone (Atavaquone) Featured |
Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
More description
|
|
| DC7361 | Asunaprevir Featured |
Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor.
More description
|
|
| DC20695 | ASTX660(Tolinapant) Featured |
ASTX660 is a novel potent IAP antagonist that targets the BIR3 domain of cIAP1/2 and XIAP with IC50 of 12 nM and <40 nM.
More description
|
|
| DC11407 | Asapiprant(BGE-175) Featured |
Asapiprant (BGE-175) is a potent and specific antagonist of human PGD2/PTGDR signaling with Ki of 0.44 nM. BGE-175 is currently in a Phase 2 clinical trial to test whether it can prevent disease progression and mortality in older patients hospitalized wit
More description
|
|
| DC3112 | AS-252424 Featured |
AS-252424 is a novel, potent and selective inhibitor of PI3Kγ with IC50 of 33 nM.
More description
|
|
| DC8181 | Filanesib(ARRY-520) Featured |
ARRY-520 is a synthetic, small molecule kinesin spindle protein (KSP) inhibitor with IC50 of 6 nM.
More description
|
|
| DC9972 | ARQ-092(Miransertib) Featured |
ARQ 092 is an oral activie, potent and selective AKT inhibitor with IC50 values: 5.0 nM (AKT1); 4.5 nM (AKT2); 16 nM (AKT3).
More description
|
|
| DC21979 | ATF6 agonist compound A147 Featured |
ATF6 agonist compound A147 is a specific, small molecule agonist of transcription factor ATF6, activates ATF6 and influences differentiation of stem cells.147 has broad antiviral activity against multiple DENV strains and serotypes and that the compound i
More description
|
|
| DC58062 | 4-Nitrophenylrhamnoside Featured |
4-Nitrophenyl α-L-rhamnopyranoside is a chromogenic substrate for naringinase.
More description
|
|
| DC60068 | PD-123319 free base Featured |
PD-123319 is a selective, nonpeptide AT2R antagonist (IC50 = 5.6 nM vs. 100 nM for AT1R). PD-123319 has been used to selectively examine the specific roles for AT1R and AT2R in hypertensive and other vascular research-related models..
More description
|
|
| DC40567 | Alkyne tyramide Featured |
Alkyne tyramide is a clickable ascorbate peroxidase 2 (APEX2) probe. Alkyne tyramide substantially improves APEX-labeling efficiency in intact yeast cells, as it is more cell wall-permeant than APEX2 substrate biotin-phenol (BP). Alkyne tyramide also faci
More description
|
|
| DC27020 | Arbidol analog Featured |
A Arbidol analog which showed affinity against both H3 (1150-fold) and H1 (98-fold) hemagglutinin
subtypes than Arbidol.
More description
|
|
| DC9022 | Amifostine Featured |
Amifostine (WR2721) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer.
More description
|
|
| DC8285 | Acotiamide HCl Featured |
Acotiamide monohydrochloride trihydrate is an orally active and first-in-class gastroprokinetic agent for the treatment of functional dyspepsia. Acotiamide monohydrochloride trihydrate enhances acetylcholine released by enteric neurons through muscarinic
More description
|
|
| DC12636 | Apararenone Featured |
Apararenone (MT-3995) is a novel potent, selective non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis..
More description
|
|
| DC20078 | AP1867 Featured |
AP1867 is a synthetic FKBP12F36V-directed ligand.
More description
|
|
| DC20664 | AMG-548 Featured |
AMG-548 is a potent and selective inhibitor of p38α with Ki of 0.5 nM, dispalys weak inhibition for p38β (Ki=3.6 nM), and >5,000-fold selectivity over p38γ and p38δ; shows >1,000-fold selectivity over other 36 kinases, and is efficacious in acute and chro
More description
|
|
| DC10209 | ALW-II-41-27 Featured |
ALW-II-41-27 is a novel Eph receptor tyrosine kinase inhibitor, used for cancer treatment.
More description
|
|
| DC9402 | Letermovir(AIC-246) Featured |
AIC246 is a novel anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
More description
|
|
| DC7050 | ADL5859 HCl Featured |
ADL5859 agonizes δ-opioid receptor with a 1000-fold selectivity than µ- or κ-opioid receptor with Ki of 32 nM and 37 nM, respectively.ADL5859 displays weak inhibitory activity at the hERG channel with an IC50 of 78 μM. The EC50 of ADL5859 against δ opioid
More description
|
|
| DC10633 | AD80 Featured |
AD80, a multikinase inhibitor, shows strong activity against human RET, BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.
More description
|
|
| DC9900 | Acetaminophen Featured |
Acetaminophen is a COX inhibitor for COX-1 and COX-2 with IC50 of 113.7 μM and 25.8 μM, respectively.
More description
|
|
| DC23182 | ABX464 Featured |
ABX464 (ABX-464, ABX 464) is a novel class of anti-HIV small molecule targeting Rev-mediated viral RNA biogenesis, shows dose dependent inhibition of HIV-1 replication in stimulated PBMCs with IC50 of 0.1-0.5 uM.
More description
|
|
| DC11299 | ABC 1183 Featured |
ABC1183 is a potent, selective, orally active GSK3α/β and CDK9 inhibitor with IC50 of 327/657 nM and 321 nM (CDK9/cyclin T1), shows growth inhibitory activity against a broad panel of cancer cell lines; decreases cell survival through G2/M arrest and modu
More description
|
|
| DC21981 | CD73 inhibitor AB-680 Featured |
AB680 (AB-680) is a highly potent, selective, reversible inhibitor of CD73 with Ki/IC50 of 4.9/70 pM (hCD73), displays > 10,000-fold selectivity against related ecto-nucleotidases (CD39, NTPDases 2/3/8) and a large panel of unrelated enzymes, receptors, a
More description
|
|
| DC12702 | A1874 Featured |
A1874 (A-1874) is a nutlin-based and BRD4-degrading PROTAC with DC50 of 32 nM (induce BRD4 degradation in cells).
More description
|
|
| DC7517 | THIACETAZONE Featured |
A thiosemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens. Thiacetazone containing regimens are less effective than the short-course regimen recommended by the I
More description
|
|
| DC24191 | Cyclophosphamide hydrate Featured |
A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.
More description
|
|
| DC23210 | SZL P1-41 Featured |
A small molecule Skp2 E3 ligase inhibitor that prevents Skp2-Skp1 interaction and Skp2 SCF E3 ligase activity in vitro.
More description
|
|
| DC23938 | Esomeprazole sodium Featured |
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells.
More description
|
|